---
title: "MENS.US (MENS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MENS.US/news.md"
symbol: "MENS.US"
name: "MENS.US"
parent: "https://longbridge.com/en/quote/MENS.US.md"
datetime: "2026-03-08T07:10:17.619Z"
locales:
  - [en](https://longbridge.com/en/quote/MENS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MENS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MENS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MENS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MENS.US/news.md)


# MENS.US (MENS.US) — Related News

### [Jyong Biotech (NASDAQ:MENS) Stock Price Down 12.3%  - Time to Sell?](https://longbridge.com/en/news/277012024.md)
*2026-02-26T09:08:23.000Z*
> Shares of Jyong Biotech (NASDAQ:MENS) fell 12.3% to $2.42, with trading volume down 34% from average levels. Analysts ha

### [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://longbridge.com/en/news/276938119.md)
*2026-02-25T21:07:13.000Z*
> In Wednesday's after-market session, CASI Pharmaceuticals saw a significant gain of 54.2%, reaching $0.32, while Curanex

### [12 Health Care Stocks Moving In Monday's Intraday Session](https://longbridge.com/en/news/276628576.md)
*2026-02-23T17:05:36.000Z*
> In Monday's intraday session, Arcellx (ACLX) shares surged 77.6% to $113.83, while Vanda Pharmaceuticals (VNDA) rose 40.

### [Jyong Biotech Ltd. Appoints Wei Zhang as Chief Financial Officer](https://longbridge.com/en/news/275174584.md)
*2026-02-06T21:31:51.000Z*
> Jyong Biotech Ltd. has appointed Wei (Vivi) Zhang as its new Chief Financial Officer, effective February 6, 2026, replac

### [U.S. stock market midday update: Jyong Biotech up 19.28%, trading volume surges, market sentiment is high but beware of volatility risks](https://longbridge.com/en/news/275160539.md)
*2026-02-06T18:03:08.000Z*
> Jyong Biotech rose 19.28%; AbbVie rose 2.22%, with a transaction volume of USD 621 million; Gilead Sciences rose 1.55%, 

### [](https://longbridge.com/en/news/275047686.md)
*2026-02-05T23:56:53.000Z*
> The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Phar

### [Jyong Biotech Reports Phase II Trial Results Showing MCS-8 Lowers Cholesterol and May Prevent Prostate Cancer](https://longbridge.com/en/news/274317161.md)
*2026-01-30T13:30:55.000Z*
> Jyong Biotech Ltd. has reported results from its Phase II clinical trial of MCS-8, showing a significant reduction in ch

### [](https://longbridge.com/en/news/274061220.md)
*2026-01-28T23:57:00.000Z*
> The Nasdaq Biotechnology Index fell by approximately 1.7%. Among the constituent stocks, Regenxbio dropped 17.90%, Altim

### [Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update](https://longbridge.com/en/news/272564339.md)
*2026-01-14T14:00:37.000Z*
> Jyong Biotech Ltd. (NASDAQ:MENS) experienced a significant rise in short interest, increasing by 157.2% in December, tot

### [U.S. stock market midday update: Warning signals emerge frequently, policy divergence and lowered earnings expectations lead to a 13.35% plunge in Jyong Biotech](https://longbridge.com/en/news/271021771.md)
*2025-12-29T18:02:12.000Z*
> Jyong Biotech fell 13.35%; Ultragenyx Pharmaceutical fell 44.19%, with a transaction volume of USD 250 million; Amgen fe